Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119237872 | 11923787 | 2 | F | 20160912 | 20160118 | 20160915 | EXP | US-ROCHE-1439211 | ROCHE | , UPPAL N, WAGNER S, BENDELL J, THADDEUS B, WADE, S, NEMUNAITIS J, STELLA P, PIPAS J, WAINBERG Z, MANGES R, GARRETT W, HUNTER D, CLARK J, LEOPOLD L, LEVY R AND SANDOR V. RESULTS FROM A PHASE 2 STUDY OF RUXOLITINIB OR PLACEBO WITH CAPECITABINE AS SECOND-LINE THERAPY IN PATIENTS WITH METASTATIC PANCREATIC CANCER: THE RECAP TRIAL. ANNALS OF ONCOLOGY 2014 JUN;25(SUPP 2):II115-II116. | 0.00 | Y | 0.00000 | 20160915 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119237872 | 11923787 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | FROM DAYS 1-14 OF A 21-DAY CYCLE. | U | 20896 | 1000 | MG/M**2 | BID | ||||||
119237872 | 11923787 | 2 | SS | RUXOLITINIB | RUXOLITINIB | 1 | Oral | ON DAYS 1-21 OF A 21-DAY CYCLE | U | 0 | 15 | MG | TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119237872 | 11923787 | 1 | Pancreatic carcinoma metastatic |
119237872 | 11923787 | 2 | Pancreatic carcinoma metastatic |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119237872 | 11923787 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119237872 | 11923787 | Abdominal pain | |
119237872 | 11923787 | Abdominal pain upper | |
119237872 | 11923787 | Anaemia | |
119237872 | 11923787 | Ascites | |
119237872 | 11923787 | Asthenia | |
119237872 | 11923787 | Back pain | |
119237872 | 11923787 | Constipation | |
119237872 | 11923787 | Decreased appetite | |
119237872 | 11923787 | Deep vein thrombosis | |
119237872 | 11923787 | Dehydration | |
119237872 | 11923787 | Diarrhoea | |
119237872 | 11923787 | Dizziness | |
119237872 | 11923787 | Embolism | |
119237872 | 11923787 | Fatigue | |
119237872 | 11923787 | Hyponatraemia | |
119237872 | 11923787 | Hypotension | |
119237872 | 11923787 | Nausea | |
119237872 | 11923787 | Neutropenia | |
119237872 | 11923787 | Oedema peripheral | |
119237872 | 11923787 | Palmar-plantar erythrodysaesthesia syndrome | |
119237872 | 11923787 | Peripheral sensory neuropathy | |
119237872 | 11923787 | Pneumonia | |
119237872 | 11923787 | Pneumonia aspiration | |
119237872 | 11923787 | Pneumonia klebsiella | |
119237872 | 11923787 | Portal vein thrombosis | |
119237872 | 11923787 | Pulmonary embolism | |
119237872 | 11923787 | Pyrexia | |
119237872 | 11923787 | Stomatitis | |
119237872 | 11923787 | Thrombocytopenia | |
119237872 | 11923787 | Thrombosis | |
119237872 | 11923787 | Trousseau's syndrome | |
119237872 | 11923787 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |